Authors:
Henson, BS
Inglehart, MR
Eisbruch, A
Ship, JA
Citation: Bs. Henson et al., Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy, ORAL ONCOL, 37(1), 2001, pp. 84-93
Authors:
Eisbruch, A
Shewach, DS
Bradford, CR
Littles, JF
Teknos, TN
Chepeha, DB
Marentette, LJ
Terrell, JE
Hogikyan, ND
Dawson, LA
Urba, S
Wolf, GT
Lawrence, TS
Citation: A. Eisbruch et al., Radiation concurrent with gemcitabine for locally advanced head and neck cancer: A phase I trial and intracellular drug incorporation study, J CL ONCOL, 19(3), 2001, pp. 792-799
Authors:
Eisbruch, A
Kim, HM
Terrell, JE
Marsh, LH
Dawson, LA
Ship, JA
Citation: A. Eisbruch et al., Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer, INT J RAD O, 50(3), 2001, pp. 695-704
Authors:
Reynolds, C
Ratanatharathorn, V
Adams, P
Braun, T
Silver, S
Ayash, L
Carson, E
Eisbruch, A
Dawson, LA
McDonagh, K
Ferrara, J
Uberti, J
Citation: C. Reynolds et al., Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma, BONE MAR TR, 27(8), 2001, pp. 801-807
Citation: A. Eisbruch et Rk. Ten Haken, Comments on the use of the Lyman-Kutcher-Burman model to describe tissue response to nonuniform irradiation - Reply, INT J RAD O, 47(5), 2000, pp. 1459-1460
Authors:
Fields, MT
Eisbruch, A
Normolle, D
Orfall, A
Davis, MA
Pu, AT
Lawrence, TS
Citation: Mt. Fields et al., Radiosensitization produced in vivo by once- vs. twice-weekly 2 ' 2 '-difluoro-2 '-deoxycytidine (gemcitabine), INT J RAD O, 47(3), 2000, pp. 785-791
Authors:
Dawson, LA
Anzai, Y
Marsh, L
Martel, MK
Paulino, A
Ship, JA
Eisbruch, A
Citation: La. Dawson et al., Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer, INT J RAD O, 46(5), 2000, pp. 1117-1126
Authors:
Henson, BS
Eisbruch, A
D'Hondt, E
Ship, JA
Citation: Bs. Henson et al., Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment, ORAL ONCOL, 35(3), 1999, pp. 234-241
Authors:
Fraass, BA
Kessler, ML
McShan, DL
Marsh, LH
Watson, BA
Dusseau, WJ
Eisbruch, A
Sandler, HM
Lichter, AS
Citation: Ba. Fraass et al., Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy, SEM RAD ONC, 9(1), 1999, pp. 60
Authors:
Eisbruch, A
Robertson, JM
Johnston, CM
Tworek, J
Reynolds, KR
Roberts, JA
Lawrence, TS
Citation: A. Eisbruch et al., Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: A phase I and drug incorporation study, J CL ONCOL, 17(1), 1999, pp. 31-40
Authors:
Eisbruch, A
Ten Haken, RK
Kim, HM
Marsh, LH
Ship, JA
Citation: A. Eisbruch et al., Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer, INT J RAD O, 45(3), 1999, pp. 577-587